Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 06, 2016 7:21 AM ET


Company Overview of Eagle Pharmaceuticals Inc.

Company Overview

Eagle Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The company offers argatroban to treat heparin-induced thrombocytopenia; and Ryanodex injectable suspension for the treatment of malignant hyperthermia. It develops EP-3101, a bendamustine ready to dilute (RTD) liquid and EP-3102, a bendamustine short infusion time RTD liquid for the treatment of chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma;; and EP-4104, a dantrolene for the treatment of exertional heat stroke. The company also develops EP-5101 (pemetrexed) as RTD liquid, whi...

50 Tice Boulevard

Suite 315

Woodcliff Lake, NJ 07677

United States

Founded in 2007

39 Employees



Key Executives for Eagle Pharmaceuticals Inc.

Chief Executive Officer, President, Director and Member of Executive Committee
Age: 55
Total Annual Compensation: $449.6K
Chief Financial Officer
Age: 62
Total Annual Compensation: $265.9K
Chief Scientific Officer and Executive Vice President
Age: 56
Total Annual Compensation: $352.4K
Compensation as of Fiscal Year 2014.

Eagle Pharmaceuticals Inc. Key Developments

Eagle Pharmaceuticals, Inc. Appoints Michael Moran as U.S. Head of Sales

Eagle Pharmaceuticals Inc. announced that it has appointed Michael Moran to the role of U.S. Head of Sales, effective immediately. Michael Moran is an industry veteran with more than 15 years of experience in pharmaceutical sales. Prior to joining Eagle he spent seven years in various leadership roles at GlaxoSmithKline, including most recently the role of field vice president.

Eagle Pharmaceuticals Announces Commercial Availability of Docetaxel Injection

Eagle Pharmaceuticals announced the shipment and commercial availability of Alcohol-Free Docetaxel Injection (“Docetaxel Injection”). Docetaxel Injection is approved for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer. Docetaxel Injection is the first alcohol-free formulation approved in the U.S. Additional features of this product are: presents as one, pre-filled vial that does not require mixing; is available in three different dosages: 20mg/1ml, 80mg/4mL, and 160mg/8mL; and 24 hours of stability at final dilution strength.

FDA Grants Fast Track Designation to Eagle Pharmaceuticals Inc.'s RYANODEX for Treatment of Exertional Heat Stroke

Eagle Pharmaceuticals announced that the U.S. Food and Drug Administration has granted Fast Track designation to its RYANODEX (dantrolene sodium for injectable suspension) for the treatment of exertional heat stroke, an investigational new indication for the product. The FDA's Fast Track program facilitates the development and review of drugs intended to treat serious conditions and address an unmet medical need. A drug development program with Fast Track designation is afforded greater access to the FDA for the purpose of expediting the drug's development, review and potential approval to get important new drugs to the patient earlier.

Similar Private Companies By Industry

Company Name Region
Biomat USA, Inc. United States
mAbVista, Inc. United States
Amunix Operating Inc. United States
Chaperone Technologies, Inc. United States
NEONC Technologies, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Eagle Pharmaceuticals Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at